Lessons from the GHOST-EU registry

Azeem Latib, Davide Capodanno, Maciej Lesiak, Corrado Tamburino, Antonio Colombo

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Bifurcations are increasingly being treated with bioresorbable vascular scaffolds (BVS) and accounted for about 25% of patients treated in the large multicentre GHOST-EU registry. This registry, along with bench testing, has provided a glimpse of the techniques and limitations of treating bifurcations with BVS. The provisional strategy remains the default approach to bifurcation treatment with BVS. If correctly performed, SB dilatation, T-kissing inflation, crossover to side branch stenting and elective double stenting are feasible without causing scaffold disruption. Theoretically, when the scaffolds are resorbed, the normal bifurcation anatomy, flow and vascular function will be restored, while jailed SBs will be liberated. However, data from the GHOST-EU registry are awaited to confirm the long-term safety and efficacy of BVS in coronary bifurcations.

Original languageEnglish (US)
Pages (from-to)V170-V174
StatePublished - May 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Lessons from the GHOST-EU registry'. Together they form a unique fingerprint.

Cite this